Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension

Gérald Simonneau, Marius M. Hoeper

Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016

Journal Issue: February

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gérald Simonneau, Marius M. Hoeper. Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension. Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012
Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015
Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009
Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding Source: Eur Respir J 2013; 41: 462-468 Year: 2013
Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014
Chronic thromboembolic pulmonary hypertension and associated medical conditions Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009
Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history Source: Eur Respir Rev 2009; 18: 170-173 Year: 2009
ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021
Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007
The changing landscape of chronic thromboembolic pulmonary hypertension management Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017 Year: 2017
The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020 Year: 2021
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature Source: Eur Respir J , 49 (2) 1601792; DOI: 10.1183/13993003.01792-2016 Year: 2017
Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017
Pulmonary embolism and the consequences for the right heart Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136 Year: 2006